Calcium-dependent block of P2X7 receptor channel function is allosteric

Journal of General Physiology

Volumn 138, Issue 4, 2011, Pages 437-452

  Yan, Zonghe ^a   Khadra, Anmar ^b   Sherman, Arthur ^b   Stojilkovic, Stanko S ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARBENOXOLONE; PURINERGIC P2X7 RECEPTOR;

ALLOSTERISM; ARTICLE; BIOLOGICAL MODEL; CELL STRAIN HEK293; CHANNEL GATING; DOSE RESPONSE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; PROBABILITY;

ALLOSTERIC REGULATION; CALCIUM; CARBENOXOLONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; ION CHANNEL GATING; KINETICS; MARKOV CHAINS; MODELS, BIOLOGICAL; RECEPTORS, PURINERGIC P2X7;

EID: 80054018926     PISSN: 00221295     EISSN: 15407748     Source Type: Journal    
DOI: 10.1085/jgp.201110647     Document Type: Article

References (38)

1. Acuña-Castillo, C., C. Coddou, P. Bull, J. Brito, and J.P. Huidobro-Toro. 2007. Differential role of extracellular histidines in copper, zinc, magnesium and proton modulation of the P2X7 purinergic receptor. J. Neurochem. 101:17-26. http://dx.doi.org/10.1111/j.1471-4159.2006.04343.x.
2. Bianchi, M.T., and R.L. Macdonald. 2001. Agonist trapping by GABAA receptor channels. J. Neurosci. 21:9083-9091.
3. Browne, L.E., L.H. Jiang, and R.A. North. 2010. New structure enlivens interest in P2X receptors. Trends Pharmacol. Sci. 31:229-237. http://dx.doi.org/10.1016/j.tips.2010.02.004
4. Chaumont, S., and B.S. Khakh. 2008. Patch-clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels. Proc. Natl. Acad. Sci. USA. 105:12063-12068. http://dx.doi.org/10.1073/pnas.0803008105
5. Chessell, I.P., A.D. Michel, and P.P. Humphrey. 1997. Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br. J. Pharmacol. 121:1429-1437. http://dx.doi.org/10.1038/sj.bjp.0701278
6. Cockcroft, S., and B.D. Gomperts. 1979. Activation and inhibition of calcium-dependent histamine secretion by ATP ions applied to rat mast cells. J. Physiol. 296:229-243.
7. Coddou, C., Z. Yan, T. Obsil, J.P. Huidobro-Toro, and S.S. Stojilkovic. 2011. Activation and regulation of purinergic P2X receptor channels. Pharmacol. Rev. 63:641-683. http://dx.doi.org/10.1124/pr.110.003129
8. Colquhoun, D. 1998. Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br. J. Pharmacol. 125:923-947. http://dx.doi.org/10.1038/sj.bjp.0702164
9. Dahlquist, R., and B. Diamant. 1974. Interaction of ATP and calcium on the rat mast cell: effect on histamine release. Acta Pharmacol. Toxicol. (Copenh.). 34:368-384. http://dx.doi.org/10.1111/j.1600-0773.1974.tb03533.x
10. Di Virgilio, F., P. Chiozzi, S. Falzoni, D. Ferrari, J.M. Sanz, V. Venketaraman, and O.R. Baricordi. 1998. Cytolytic P2X purinoceptors. Cell Death Differ. 5:191-199. http://dx.doi.org/10.1038/sj.cdd.4400341
11. Dubyak, G.R. 2009. Both sides now: multiple interactions of ATP with pannexin-1 hemichannels. Focus on "A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP". Am. J. Physiol. Cell Physiol. 296:C235-C241. http://dx.doi.org/10.1152/ajpcell.00639.2008
12. Egan, T.M., D.S. Samways, and Z. Li. 2006. Biophysics of P2X receptors. Pflugers Arch. 452:501-512. http://dx.doi.org/10.1007/s00424-006-0078-1
13. He, M.L., H. Zemkova, T.A. Koshimizu, M. Tomić, and S.S. Stojilkovic. 2003. Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels. Am. J. Physiol. Cell Physiol. 285:C467-C479.
14. Jahngen, J.H., and E.F. Rossomando. 1983. Resolution of an ATP-metal chelate from metal-free ATP by reverse-phase high-performance liquid chromatography. Anal. Biochem. 130:406-415. http://dx.doi.org/10.1016/0003-2697(83)90608-5
15. Jiang, L.H. 2009. Inhibition of P2X(7) receptors by divalent cations: old action and new insight. Eur. Biophys. J. 38:339-346. http://dx.doi.org/10.1007/s00249-008-0315-y
16. Khakh, B.S., X.R. Bao, C. Labarca, and H.A. Lester. 1999. Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat. Neurosci. 2:322-330. http://dx.doi.org/10.1038/7233
17. Klapperstück, M., C. Büttner, T. Böhm, G. Schmalzing, and F. Markwardt. 2000. Characteristics of P2X7 receptors from human B lymphocytes expressed in Xenopus oocytes. Biochim. Biophys. Acta. 1467:444-456. http://dx.doi.org/10.1016/S0005-2736(00)00245-5
18. Klapperstück, M., C. Büttner, G. Schmalzing, and F. Markwardt. 2001. Functional evidence of distinct ATP activation sites at the human P2X(7) receptor. J. Physiol. 534:25-35. http://dx.doi.org/10.1111/j.1469-7793.2001.00025.x
19. Li, S., I. Bjelobaba, Z. Yan, M. Kucka, M. Tomic, and S.S. Stojilkovic. 2011. Expression and roles of pannexins in ATP release in the pituitary gland. Endocrinology. 152:2342-2352. http://dx.doi.org/10.1210/en.2010-1216
20. Marquez-Klaka, B., J. Rettinger, Y. Bhargava, T. Eisele, and A. Nicke. 2007. Identification of an intersubunit cross-link between substituted cysteine residues located in the putative ATP binding site of the P2X1 receptor. J. Neurosci. 27:1456-1466. http://dx.doi.org/10.1523/JNEUROSCI.3105-06.2007
21. McGaraughty, S., K.L. Chu, M.T. Namovic, D.L. Donnelly-Roberts, R.R. Harris, X.F. Zhang, C.C. Shieh, C.T. Wismer, C.Z. Zhu, D.M. Gauvin, et al. 2007. P2X7-related modulation of pathological nociception in rats. Neuroscience. 146:1817-1828. http://dx.doi.org/10.1016/j.neuroscience.2007.03.035
22. Michel, A.D., I.P. Chessell, and P.P. Humphrey. 1999. Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch. Pharmacol. 359:102-109. http://dx.doi.org/10.1007/PL00005328
23. Nelson, D.W., R.J. Gregg, M.E. Kort, A. Perez-Medrano, E.A. Voight, Y. Wang, G. Grayson, M.T. Namovic, D.L. Donnelly-Roberts, W. Niforatos, et al. 2006. Structure-activity relationshipstudies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J. Med. Chem. 49:3659-3666. http://dx.doi.org/10.1021/jm051202e
24. Nicke, A. 2008. Homotrimeric complexes are the dominant assembly state of native P2X7 subunits. Biochem. Biophys. Res. Commun. 377:803-808. http://dx.doi.org/10.1016/j.bbrc.2008.10.042
25. North, R.A. 2002. Molecular physiology of P2X receptors. Physiol. Rev. 82:1013-1067.
26. Pelegrin, P., and A. Surprenant. 2006. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25:5071-5082. http://dx.doi.org/10.1038/sj.emboj.7601378
27. Petrou, S., M. Ugur, R.M. Drummond, J.J. Singer, and J.V. Walsh Jr. 1997. P2X7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype. FEBS Lett. 411:339-345. http://dx.doi.org/10.1016/S0014-5793(97)00700-X
28. Rettinger, J., and G. Schmalzing. 2004. Desensitization masks nanomolar potency of ATP for the P2X1 receptor. J. Biol. Chem. 279:6426-6433. http://dx.doi.org/10.1074/jbc.M306987200
29. Roger, S., P. Pelegrin, and A. Surprenant. 2008. Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. J. Neurosci. 28:6393-6401. http://dx.doi.org/10.1523/JNEUROSCI.0696-08.2008
30. Shinozaki, Y., K. Sumitomo, M. Tsuda, S. Koizumi, K. Inoue, and K. Torimitsu. 2009. Direct observation of ATP-induced conformational changes in single P2X4 receptors. PLoS Biol. 7:e103. http://dx.doi.org/10.1371/journal.pbio.1000103
31. Surprenant, A. 1996. Functional properties of native and cloned P2X receptors. Ciba Found. Symp. 198:208-219.
32. Surprenant, A., F. Rassendren, E. Kawashima, R.A. North, and G. Buell. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 272:735-738. http://dx.doi.org/10.1126/science.272.5262.735
33. Torres, G.E., T.M. Egan, and M.M. Voigt. 1999. Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J. Biol. Chem. 274:6653-6659. http://dx.doi.org/10.1074/jbc.274.10.6653
34. Virginio, C., D. Church, R.A. North, and A. Surprenant. 1997. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology. 36:1285-1294. http://dx.doi.org/10.1016/S0028-3908(97)00141-X
35. Yan, Z., Z. Liang, M. Tomic, T. Obsil, and S.S. Stojilkovic. 2005. Molecular determinants of the agonist binding domain of a P2X receptor channel. Mol. Pharmacol. 67:1078-1088. http://dx.doi.org/10.1124/mol.104.010108
36. Yan, Z., Z. Liang, T. Obsil, and S.S. Stojilkovic. 2006. Participation of the Lys313-Ile333 sequence of the purinergic P2X4 receptor in agonist binding and transduction of signals to the channel gate. J. Biol. Chem. 281:32649-32659. http://dx.doi.org/10.1074/jbc.M512791200
37. Yan, Z., S. Li, Z. Liang, M. Tomic, and S.S. Stojilkovic. 2008. The P2X7 receptor channel pore dilates under physiological ion conditions. J. Gen. Physiol. 132:563-573. http://dx.doi.org/10.1085/jgp.200810059
38. Yan, Z., A. Khadra, S. Li, M. Tomic, A. Sherman, and S.S. Stojilkovic. 2010. Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J. Neurosci. 30:14213-14224. http://dx.doi.org/10.1523/JNEUROSCI.2390-10.2010